Paroxetine controlled-release formulation in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled study in Japan and Korea.

@article{Higuchi2011ParoxetineCF,
  title={Paroxetine controlled-release formulation in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled study in Japan and Korea.},
  author={Teruhiko Higuchi and Jin Pyo Hong and Hee Yeon Jung and Yoshinori Watanabe and Taro Kunitomi and Kunitoshi Kamijima},
  journal={Psychiatry and clinical neurosciences},
  year={2011},
  volume={65 7},
  pages={655-63}
}
AIM The main purpose of this study was to evaluate the efficacy of paroxetine controlled-release (CR) formulation compared to placebo. A secondary objective was to test the hypothesis that the CR decreases selective-serotonin-reuptake-inhibitors-induced nausea as its formulation allows more distal gastrointestinal absorption than the paroxetine immediate-release (IR) formulation. METHODS We conducted this study in Japanese and Korean patients with major depressive disorder (MDD) in order to… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

Similar Papers

Loading similar papers…